| Year |
Citation |
Score |
| 2017 |
Zeineldin R, Syoufjy J. Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy. Methods of Molecular Biology. 1530: 3-12. PMID 28150193 DOI: 10.1007/978-1-4939-6646-2_1 |
0.31 |
|
| 2013 |
Youkhanna J, Syoufjy J, Rhorer M, Oladeinde O, Zeineldin R. Toward nanotechnology-based solutions for a particular disease: ovarian cancer as an example Nano Reviews. 2: 473-484. DOI: 10.1515/Ntrev-2013-0008 |
0.324 |
|
| 2012 |
Goncharov K, Zeineldin RR. Abstract 4227: Sensitizing resistant ovarian cancer to chemotherapy through inhibition of small GTPases Cancer Research. 72: 4227-4227. DOI: 10.1158/1538-7445.Am2012-4227 |
0.353 |
|
| 2012 |
Zeineldin R. Carbon Nanotubes for Targeted Cancer Therapy Nanotechnologies For the Life Sciences. DOI: 10.1002/9783527610419.Ntls0241 |
0.358 |
|
| 2011 |
Kim PS, Djazayeri S, Zeineldin R. Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. Gynecologic Oncology. 120: 393-403. PMID 21168905 DOI: 10.1016/J.Ygyno.2010.11.029 |
0.367 |
|
| 2011 |
Wandinger-Ness A, Kenney SR, Agola J, Roxby J, Surviladze Z, Silberberg M, Zeineldin R, Vestling A, Bologa C, Ursu O, Oprea T, Muller C, Lomo L, Sklar L, Hudson LG. Abstract LB-214: Rac1 and Cdc42 GTPases as novel targets in ovarian cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-214 |
0.652 |
|
| 2010 |
Zeineldin R, Ning Y, Hudson LG. The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 58: 529-41. PMID 20159766 DOI: 10.1369/Jhc.2010.955104 |
0.705 |
|
| 2010 |
Zeineldin R, Muller CY, Stack MS, Hudson LG. Targeting the EGF receptor for ovarian cancer therapy. Journal of Oncology. 2010: 414676. PMID 20066160 DOI: 10.1155/2010/414676 |
0.665 |
|
| 2009 |
Hudson LG, Zeineldin R, Silberberg M, Stack MS. Activated epidermal growth factor receptor in ovarian cancer. Cancer Treatment and Research. 149: 203-26. PMID 19763438 DOI: 10.1007/978-0-387-98094-2_10 |
0.649 |
|
| 2009 |
Zeineldin R, Al-Haik M, Hudson LG. Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells. Nano Letters. 9: 751-7. PMID 19152309 DOI: 10.1021/Nl8033174 |
0.63 |
|
| 2008 |
Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clinical & Experimental Metastasis. 25: 643-55. PMID 18398687 DOI: 10.1007/S10585-008-9171-5 |
0.637 |
|
| 2007 |
Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Molecular Cancer Research : McR. 5: 413-21. PMID 17475671 DOI: 10.1158/1541-7786.Mcr-07-0019 |
0.637 |
|
| 2006 |
Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Molecular Carcinogenesis. 45: 851-60. PMID 16788982 DOI: 10.1002/Mc.20237 |
0.682 |
|
| 2006 |
Zeineldin R, Hudson LG. Epithelial cell migration in response to epidermal growth factor. Methods in Molecular Biology (Clifton, N.J.). 327: 147-58. PMID 16780219 DOI: 10.1385/1-59745-012-X:147 |
0.651 |
|
| 2005 |
Ning Y, Zeineldin R, Liu Y, Rosenberg M, Stack MS, Hudson LG. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation. Cancer Research. 65: 9280-6. PMID 16230389 DOI: 10.1158/0008-5472.Can-05-0407 |
0.726 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Skandani AA, Zeineldin R, Al-Haik M. Effect of Chirality and Length on the Penetrability of Single-Walled Carbon Nanotubes into Lipid Bilayer Cell Membranes Langmuir. 28: 7872-7879. PMID 22545729 DOI: 10.1021/La3011162 |
0.265 |
|
| 1997 |
Zeineldin R, Ekborg S, Baker J. Oligomeric forms of the 148 kDa cartilage matrix protein Biochemical Journal. 328: 665-668. PMID 9371729 DOI: 10.1042/Bj3280665 |
0.254 |
|
| 2010 |
Chemburu S, Fenton K, Lopez GP, Zeineldin R. Biomimetic silica microspheres in biosensing. Molecules (Basel, Switzerland). 15: 1932-57. PMID 20336023 DOI: 10.3390/Molecules15031932 |
0.245 |
|
| 2008 |
Piyasena ME, Zeineldin R, Fenton K, Buranda T, Lopez GP. Biosensors based on release of compounds upon disruption of lipid bilayers supported on porous microspheres. Biointerphases. 3: 38. PMID 20408688 DOI: 10.1116/1.2918743 |
0.236 |
|
| 2008 |
Zeineldin R, Piyasena ME, Sklar LA, Whitten D, Lopez GP. Detection of membrane biointeractions based on fluorescence superquenching. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 4125-31. PMID 18302435 DOI: 10.1021/La703575R |
0.233 |
|
| 2006 |
Zeineldin R, Piyasena ME, Bergstedt TS, Sklar LA, Whitten D, Lopez GP. Superquenching as a detector for microsphere-based flow cytometric assays. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 69: 335-41. PMID 16604535 DOI: 10.1002/Cyto.A.20250 |
0.214 |
|
| 2006 |
Zeineldin R, Last JA, Slade AL, Ista LK, Bisong P, O'Brien MJ, Brueck SR, Sasaki DY, Lopez GP. Using bicellar mixtures to form supported and suspended lipid bilayers on silicon chips. Langmuir : the Acs Journal of Surfaces and Colloids. 22: 8163-8. PMID 16952257 DOI: 10.1021/La060817R |
0.208 |
|
| Hide low-probability matches. |